|
|
Article: Biomarkers show promise in gauging prostate ca severity.(Urology)
- Article from:
- Internal Medicine News
- Article date:
- May 1, 2005
- Author:
CopyrightCOPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ORLANDO, FLA. -- Several biomarkers that may help to distinguish aggressive forms of prostate cancer from less worrisome types could guide physicians in planning treatment, speakers reported at a symposium on prostate cancer sponsored by the American Society for Clinical Oncology.
These biomarkers are needed because widespread prostate specific antigen (PSA) testing has led to detection of numerous low-grade, mild prostate cancers in men with relatively low PSA levels (below 10 ng/mL). Many of these men receive aggressive therapy, even though the natural history of their disease indicates that active monitoring for disease progression might suffice.
Two ...